Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
DaVita HealthCare Partner
(NY:
DVA
)
161.97
+1.87 (+1.17%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DaVita HealthCare Partner
< Previous
1
2
3
4
5
6
7
Next >
Looking Into DaVita's Return On Invested Capital
May 22, 2023
Via
Benzinga
Why Buffett Loves These 3 Stocks
May 16, 2023
An interviewer once asked Warren Buffett about the worst trade he’d ever made… and he didn’t hesitate to answer… Buying Berkshire Hathaway.
Via
Benzinga
DaVita Stock Sees Rising Relative Strength
May 10, 2023
On Wednesday, DaVita stock cleared a key technical benchmark, seeing its Relative Strength (RS) Rating jump to 91, up from 78 the day before.
Via
Investor's Business Daily
The Latest Analyst Ratings for DaVita
May 09, 2023
Via
Benzinga
These 2 Stocks Are Popping -- and It Could Be Just the Beginning
May 09, 2023
Even in a down market, these companies stood out.
Via
The Motley Fool
VIX Rallies Amid Quiet Day On Wall Street
May 09, 2023
Wall Street is relatively quiet today, as investors continue to await this week's inflation data.
Via
Talk Markets
DaVita Inc. (NYSE: DVA) Making Surprising Moves in Tuesday Session
May 09, 2023
Via
Investor Brand Network
Why Shares of DaVita Were Up Tuesday
May 09, 2023
The dialysis company's raised guidance encouraged investors.
Via
The Motley Fool
DaVita (DVA) Q1 2023 Earnings Call Transcript
May 08, 2023
DVA earnings call for the period ending March 31, 2023.
Via
The Motley Fool
DaVita (DVA) Q4 2022 Earnings Call Transcript
February 22, 2023
DVA earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 09, 2023
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Via
Benzinga
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
May 09, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Here's How Much You Would Have Made Owning DaVita Stock In The Last 20 Years
January 11, 2023
Via
Benzinga
Here's How Much $1000 Invested In DaVita 20 Years Ago Would Be Worth Today
December 27, 2022
Via
Benzinga
Warren Buffett Owns More Than a 23% Stake in These 3 Stocks
April 14, 2023
Many institutional investors don't like to purchase more than a 10% stake in a company.
Via
The Motley Fool
3 Medical Device Stocks to Buy for Cutting-Edge Innovation and Growth
April 10, 2023
Medical device stocks are set to rise with an aging population and continued improvements in technology. Here are 3 stocks to watch.
Via
InvestorPlace
You Won't Believe How Much More Warren Buffett Has Made Than the Market Since 1965
March 14, 2023
The trick is waiting long enough to let the magic of compounding do its work.
Via
The Motley Fool
The 7 Best Beaten-Down Warren Buffett Stocks to Buy
February 08, 2023
Investors will want to take a close look at these beaten-down Warren Buffett stocks to buy for long-term appreciation.
Via
InvestorPlace
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
January 31, 2023
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named the SPDR S&P Biotech ETF (NYSE: XBI), saying if you "want growth,
Via
Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
December 07, 2022
Via
Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,500 Today
November 21, 2022
Via
Benzinga
Sell These 3 Stocks and Kick These Overpaid CEOs Out of Your Portfolio
December 20, 2022
Now is the time to cut your losses on some of your 2022 losers. Here are three stocks to sell whose CEOs didn’t earn their keep.
Via
InvestorPlace
Siemens Healthineers, GE Healthcare Studying Potential Deals With Medtronic's Spun Off Units
December 15, 2022
Via
Benzinga
Warren Buffett Now Owns 20% or More of These 5 Companies
November 22, 2022
Which are these big Buffett bets are the best picks for investors?
Via
The Motley Fool
$1000 Invested In DaVita 20 Years Ago Would Be Worth This Much Today
November 04, 2022
DaVita (NYSE:DVA) has outperformed the market over the past 20 years by 3.82% on an annualized basis producing an average annual return of 11.29%. Currently, DaVita has a market capitalization of $6.29...
Via
Benzinga
DaVita Earnings Perspective: Return On Capital Employed
November 03, 2022
Pulled from Benzinga Pro data, DaVita (NYSE:DVA) showed a loss in earnings since Q2, totaling $164.69 million. Sales, on the other hand, increased by 0.75% to $2.95 billion during Q3.
Via
Benzinga
Around $134 Million Bet On This Stock Up 46% Year-To-Date? 3 Stocks Insiders Are Buying
November 02, 2022
Although US stocks closed lower on Tuesday, there were a few notable insider trades.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
October 31, 2022
During Monday's session, 96 stocks hit new 52-week lows.
Via
Benzinga
Analyst Ratings for DaVita
October 31, 2022
Over the past 3 months, 5 analysts have published their opinion on DaVita (NYSE:DVA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.